Healthy Life Agritec's 66% sales jump masks auditor warnings and cash burn
Revenue grew 66% to ₹10,707 lakhs in FY26, but the auditor cited compliance gaps and operating cash flow turned deeply negative on ballooning receivables.
— 1 earlier story on Healthy Life Agritec Ltd. →What's new
- Standalone revenue rose 66% to ₹10,707 lakhs; Q4 alone contributed ₹5,189 lakhs.
- Auditor NYS & Company flagged irregular TDS, unpaid PF/ESI, and delayed GST filings.
- Operating cash flow swung to a ₹2,797 lakh outflow as trade receivables ballooned to ₹4,933 lakhs.
Why this matters
The top-line growth is real, but the auditor's qualifications and the cash-flow swing are red flags. A surge in receivables consuming new revenue is a classic working-capital trap for a small, fast-growing company. The auditor's note that inventory, debt, and cash are solely management-certified adds governance risk.
What we're watching
- Whether receivables collection improves in Q1FY27 or the cash crunch deepens.
- SEBI or tax authority action on the compliance lapses cited by the auditor.
- Consolidated vs. standalone growth divergence in coming quarters.
The full read
Healthy Life Agritec's FY26 numbers tell two different stories. The top line is strong: standalone revenue jumped 66% to ₹10,707 lakhs, with Q4 alone at ₹5,189 lakhs. Consolidated sales reached ₹22,814 lakhs. But the auditor's report and cash-flow statement reveal the cost of that growth. Trade receivables exploded from ₹1,571 lakhs to ₹4,933 lakhs, consuming all the new sales and more. Operating cash flow swung to a ₹2,797 lakhs outflow. The statutory auditor, NYS & Company, also flagged irregular TDS remittances, unpaid provident fund and ESI dues, and delayed GST filings. Worse, it could only rely on management's word for inventory, debt, and cash balances. For a company that just raised ₹2,481 lakhs in a rights issue, that's a thin safety net. The growth is there. So is the risk.
Questions answered
- How much did the company grow, and where did the growth come from?
- Standalone revenue jumped 66% to ₹10,707 lakhs, with Q4 contributing ₹5,189 lakhs—more than double the year-ago quarter. The growth is driven by scaling trading operations.
- What did the auditor say was wrong?
- NYS & Company cited irregular TDS remittances, non-payment of provident fund and ESI dues, and delayed GST return filings. It also noted that inventory, debtors, and cash balances were certified only by management, without independent verification.
- Why did cash flow turn so negative?
- Operating cash outflow was ₹2,797 lakhs, driven by a ballooning of trade receivables to ₹4,933 lakhs from ₹1,571 lakhs. The company sold more, but collected far less of the cash, straining liquidity.
- What about the rights issue money?
- The company confirmed it fully used the ₹2,481 lakhs raised in November 2025 for working capital, debt repayment, and corporate purposes, with no deviation.
Story so far
All notes on HEALTHYLIFE →- 8 Jun 2026 · 10:23 PM IST Healthy Life Agritec's 66% sales jump masks auditor warnings and cash burn
- today Healthy Life Agritec's 66% revenue growth hides a cash crunch and audit red flags